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Abstract 
Background: The carbohydrate portions of salivary glycoproteins play important roles, including mediating bac-
terial and leukocyte adhesion. Salivary glycosylation is complex. Many of its glycoproteins present ABO and Lewis 
blood group determinants. An individual’s genetic complement and secretor status govern the expression of blood 
group antigens. We queried the extent to which salivary glycosylation varies according to blood group and secretor 
status. First, we screened submandibular/sublingual and parotid salivas collected as ductal secretions for reactivity 
with a panel of 16 lectins. We selected three lectins that reacted with the largest number of glycoproteins and one 
that recognized uncommon lactosamine-containing structures. Ductal salivas representing a secretor with complex 
blood group expression and a nonsecretor with a simple pattern were separated by SDS-PAGE. Gel slices were trypsin 
digested and the glycopeptides were individually separated on each of the four lectins. The bound fractions were de-
N-glycosylated. LC–MS/MS identified the original glycosylation sites, the peptide sequences, and the parent proteins.
Results: The results revealed novel salivary N-glycosites and glycoproteins not previously reported. As compared to 
the secretor, nonsecretor saliva had higher levels of N-glycosylation albeit with simpler structures.
Conclusions: Together, the results suggested a molecular basis for inter-individual variations in salivary protein glyco-
sylation with functional implications for oral health.
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Background
Saliva—the product of the parotid, submandibular, sub-
lingual and minor salivary glands—is a complex biologi-
cal fluid that exists in two phases. The fluid phase flows 
over oral surfaces and is swallowed. Salivary components 
can also be immobilized within the oral cavity, e.g, the 
pellicle that coats the tooth surface. In both phases, saliva 
plays many critical roles in general aspects of health 
(reviewed in [1, 2]). Examples include regulation of the 
oral microbiome by modulating the adherence, growth 
and/or viability of a diverse array of organisms. Other 
important functions include promoting tissue homeo-
stasis, taste and lubrication. The critical roles of this 
body fluid are illustrated by the myriad pathologies that 
accompany xerostomia (abnormally low salivary flow), 
which include dental caries and an increased susceptibil-
ity to oral infections, e.g., candidiasis.
Saliva has inorganic as well as protein, glycoprotein, 
peptide and carbohydrate constituents. During the past 
decade, several compilations of the salivary proteome 
have been published. In total, more than 3000 proteins/
peptides have been identified (reviewed in Amado et al. 
[3]) with ductal saliva having about 400 major con-
stituents [4]. Specific salivary functions are parsed 
among these components. In addition to its well-known 
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enzymatic activity, fluid phase salivary amylase binds to 
streptococci mediating their clearance from the oral cav-
ity [5]. Saliva also contains a rich repertoire of peptides—
members of the histatin, statherin, proline rich protein, 
and cystatin families—that regulate bacterial adhesion, 
have microbicidal activity and modulate calcium phos-
phate chemistry [6, 7]. In general, the role of the carbohy-
drate motifs in body fluids is much less well understood.
Salivary glycoproteins play a particularly important 
role in oral health because their carbohydrate constitu-
ents interact with a wide array of bacteria. Interestingly, 
their glycan repertoire is, in part, genetically determined 
as these structures include the carbohydrate epitopes 
that comprise the ABO, Lewis (Le) and other blood 
group determinants. Secretor status further complicates 
glycosylation patterns. Non-secretors have an inactive 
form of fucosyltranferase 2 (FUT2), which provides the 
glycan scaffold for Leb/y and blood-type motifs [8]. Thus, 
individuals who lack this transferase should have less 
fucosylated glycoforms than secretors who have an active 
FUT2. What are the biological consequences? Many of 
these glycans serve as receptors that mediate adhesion of 
bacteria that colonize the oral cavity—e.g., the T-Ag for 
Actinomyces naeslundii; the sT-Ag for several streptococ-
cal strains [9]; and the Le determinants, sLea, Leb, and 
Lex, for H. pylori strains [10, 11]. The major glycan car-
ried by the glycosylated proline rich protein (gPRP) is a 
biantennary oligosaccharide with a difucosylated lactosa-
mine (Ley) sequence on one antenna and an unsubsti-
tuted lactosamine sequence on the other. Fusobacterium 
nucleatum, a microorganism associated with periodontal 
disease, binds to the gPRP via terminal unmodified lac-
tosamine sequences; fucosylation of this disaccharide 
blocks bacterial binding [12].
Here we asked, at a global level, whether secretor sta-
tus affects the arrangement of carbohydrate chains along 
the amino acid backbone of salivary proteins. To answer 
this question we used a modification of a workflow that 
our group devised [13]. First, we identified the lectins 
(carbohydrate binding proteins) that best discriminated 
between salivary samples from secretors vs. nonsecre-
tors. To do so, we screened parotid and submandibular/
sublingual (SMSL) salivas collected as the ductal secre-
tions from the two groups with a large panel of lectins 
that recognized various aspects of glycan structure. To 
compare the N-glycosylation sites of secretors and non-
secretors, we used columns formed from the lectins with 
the highest discriminating power or unusual specificities 
to fractionate electrophoretically separated and trypsin 
digested saliva samples from the two donor groups. After 
elution of the bound glycopeptides, the samples were 
treated with peptide-N-glycosidase F (PNGase F), an 
amidase, and the original N-glycosylation sites (NXS/T; 
X �= proline) were identified by ESI HPLC–MS/MS 
via a +1  Da mass shift at the modified Asn. Previously 
reported and novel N-glycosites were identified. Inciden-
tally, we also detected genetic polymorphisms along the 
peptide backbones some of which were novel. The impact 
of secretor status on N-oligosacharide composition was 
demonstrated by MALDI MS analyses of the released 
glycans, which showed higher degrees of fucosylation 
among the secretor oligosaccharides. Interestingly, more 
sites were identified when the saliva sample was from a 
nonsecretor. However, studies on larger number of indi-
viduals are needed to further investigate the potential 
impact of a secretor status on N-glycosite occupancy.
Results and discussion
Lectin selection
As a first step, we screened SMSL and parotid saliva sam-
ples collected as the ductal secretions from twenty indi-
viduals for reactivity with a 16-lectin panel (Additional 
file 1: Figure S1). The donors were chosen as representing 
the spectrum of glycosylation commonly observed in the 
general US population with regard to the addition of car-
bohydrate blood group determinants to the core oligo-
saccharide structures of glycoproteins. We also evaluated 
relative expression of L-selectin carbohydrate ligands, 
e.g., MECA-79 reactivity, which are added to salivary 
components [14]. From the original twenty individu-
als, we selected four with the following characteristics: 
donor (1) secretor with blood type O, Lea+, Leb+, Ley+, 
low MECA-79; donor (2) secretor with blood type B, 
Lea+, Leb+, Ley+, low MECA-79; donor (3) secretor with 
blood type O, Lea+, Leb+, Ley+, low MECA-79; and donor 
(4) nonsecretor with blood type A, Lea–, Leb–, Ley–, high 
MECA-79. The 16 lectins were chosen based on their 
carbohydrate specificity, which spanned a wide spectrum 
from elements that are commonly found in the majority 
of N-linked structures to unusual sugar sequences and/or 
linkages (Table 1). The results are shown in Fig. 1. Panel A 
shows the electrophoretic banding patterns of SMSL and 
parotid, proteins (Coomassie blue staining) and glyco-
proteins (Alcian blue silver staining), respectively. Of the 
lectins that were screened, AAL, jacalin (JAC) and wheat 
germ agglutinin (WGA) reacted with the largest number 
of bands spanning the greatest molecular weight range 
(compare Fig. 1b with Additional file 1: Figure S1). Thus, 
using the rationale that they would capture the high-
est number of N-linked glycopeptides, they were chosen 
for the separation experiments. In this regard, we also 
included the Lycopersicon esculentum agglutinin (LEA) 
lectin, which has a much narrower specificity consistent 
with the banding pattern shown in Fig. 1c, but includes 
lactosamine units that could be substrates for the addi-
tion of the Le antigens.
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Piloting the workflow
An overview of the general method that we devised is 
shown in Fig. 2. SMSL or parotid salivas were separated 
by preparative SDS-PAGE. The entire gel was hori-
zontally rastered, macerated and subjected to trypsin 
digestion. The resulting mixture of peptides and glyco-
peptides was separated on an immobilized lectin col-
umn. The bound glycopeptides were eluted and treated 
with PNGase F, removing the N-linked oligosaccharides 
and converting the asparagines to aspartic acids. LC–
MS/MS of the digest enabled sequencing of the peptides 
and identification of the original sites of carbohydrate 
attachment.
Prior to scaling up the analysis, we performed a pilot 
experiment to test the proposed workflow by analyzing 
100 µL of parotid and the same amount of SMSL saliva 
from one donor (secretor, blood type O, Lea-, Leb−, Ley−, 
and MECA-79 low). The electrophoretically separated 
samples were rastered into 12 gel slices and chromato-
graphed on immobilized AAL. LC–MS/MS analyses, a 
total of 24 runs, identified 31 N-glycosites from 21 glyco-
proteins (Fig. 3). To our knowledge, 4 were not previously 
reported in saliva: IGHG2_HUMAN@176 (Ig gamma-2 
chain C region), PRB3_HUMAN@66 (Basic salivary 
proline-rich protein 3), PSG1_HUMAN@104 and @111 
(Pregnancy-specific beta-1-glycoprotein 1), the latter two 
within the same tryptic peptide. The PSG1 N-glycosites 
sites were recently reported in the N-glycoproteome of 
human metastatic hepatocellular carcinoma cell lines 
[15]. At the glycoprotein level, IGHG2_HUMAN and 
PRB3_HUMAN were known salivary components [16, 
17]; the detection of PSG1_Human in this body fluid was 
novel. This was despite the fact that the reproductive 
age, female donor was not pregnant at the time of sam-
ple collection. Nevertheless, this finding raises the inter-
esting possibility that this family of glycoproteins, which 
are produced in large amounts by the placenta and cir-
culate at high levels in maternal blood, can be detected 
in saliva during pregnancy. Whether their levels could be 
indicative of the placental dysfunction that is associated 
with complications such as preeclampsia is an interesting 
question that could be addressed in the future. Finally, we 
note that future studies are necessary to validate these 
new glycosites since chemical deamidation of asparagine 
residues during sample preparation can potentially lead 
to false positive identification of glycosites [18, 19].
The majority of identified N-glycosites and associ-
ated glycoproteins were identified in SMSL secretions, 
with parotid saliva contributing only two unique N-gly-
cosites, N83 and N90, within the same tryptic peptide of 
PIGR_HUMAN (Polymeric Ig receptor). The undersam-
pling limitations of the data-dependent ‘shotgun’ mode 
of data acquisition that was utilized did not allow for 
unequivocal conclusions about the absence of specific 
N-glycosites in a sample [20], a question that would best 
be answered with targeted analyses. Of note, a recently 
published library containing selected reaction monitor-
ing assays that were developed to enable antibody-inde-
pendent MS-based analyses of potential N-glycosylation 
sites in body fluids included a number of peptide targets 
Table 1 Lectins and their carbohydrate binding specificities used to screen SMSL and parotid saliva
Name Carbohydrate sequence(s) References
Artocarpus integrifolia (Jacalin) Galβ1-3GalNAc, Galα1-6Gal [62]
Erythrina christagalli (ECA) Galβ1-4GlcNAc [63]
Arachis hypogaea (peanut, PNA) Galβ1-3GalNAc [64]
Glycine max (soybean, SBA) GalNAcα1-3GalNAc
GalNAcα/β1-3/4Gal
[65]
Vicia villosa (VVA) GalNAc-Ser [66]
Datura stramonium (DSA) (GlcNAcβ1-4)2-4, Galβ1-4GlcNAc [67]
Lycopersicon esculentum (tomato, LEA) (GlcNAcβ1-4)1-4 [68]
Triticum vulgare (wheat germ, WGA) (GlcNAcβ1-4)2-5, Neu5Ac [69, 70]
Manβ1-4GlcNAcβ1-4GlacNAc [71]
Canavalia ensiformis (Con A) Branched N-linked hexa-saccharide [72]
Galanthus nivalis (GNA) Manα1-3Man [73]
Lens culinaris (LCA) Fucα1-6GlcNAc-N-Asn containing N-linked oligosaccharides [72]
Aleuria aurantia (AAL) Fucα1-6/3GlcNAc [74]
Lotus tetragonolobus (LTA) Fucα1-2Galβ1-4(Fucα1-3)GlcNAc [75]
Sambucus nigra (SNA) Neu5Acα2-6Gal/GalNAc [76]
Evonymus europaeus (EEA) Galα1-3(Fucα1-2)Galβ1-3/4GlcNAc [77]
Phaseolus vulgaris erythroagglutinating (PHA-E) N-linked bi-antennary [78]
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identified in this study (see Additional file  2: Table S1) 
[21]. In conclusion, the results of the pilot experiment 
demonstrated the feasibility of applying, to SMSL and 
parotid salivas, a workflow combining protein fractiona-
tion (via SDS-PAGE), in-gel trypsin digestion, lectin cap-
ture of glycopeptides carrying N-linked oligosaccharides, 
and LC–MS/MS identification for profiling glycosylation 
patterns in saliva.
The effects of secretor status on N‑glycosylation patterns
Salivary glycoproteins display a diverse carbohydrate 
repertoire due, in part, to the addition of blood group 
determinants to many oligosaccharides. Therefore, we 
were interested, at a global level, in the effects of this 
phenomenon on N-linked glycosylation patterns. To 
address this point, we applied the method outlined in 
Fig.  2 to 500  µL of SMSL or parotid saliva, expanding 
the rastering of the SDS-PAGE gels to 18 slices and the 
LC–MS/MS runs to 300, for the analysis of SMSL and 
parotid samples at both ends of the glycosylation spec-
trum. All results presented in this section were generated 
using saliva samples from two donors, a secretor and a 
nonsecretor.
The first donor was a secretor with blood type AB 
and complex patterns of terminal fucosylation as deter-
mined by broad Le immunoreactivity (anti-Lea, anti-Leb 
and anti-Ley) and relatively low levels of the MECA-79 
epitope (Fig. 4a). The second donor with the simplest pat-
tern was a nonsecretor with blood type O. Immunoblot-
ting revealed that the salivary secretions displayed Lea+, 
but were Leb− and Ley− with high levels of MECA-79 
immunoreactivity (Fig.  4a). An overview of the protein 
composition of the samples, as determined by SDS-
PAGE showed similar patterns to those observed in saliva 
Fig. 1 Selection of lectins for capturing human salivary N-glycosites. 
a The electrophoretic banding patterns of submandibular/sublingual 
(SMSL) and parotid (PS) salivary proteins and glycoproteins as visual-
ized by Coomassie blue or Alcian blue silver staining, respectively. 
Replicate blots were screened against a panel of 16 lectins (Addi-
tional file 1: Figure S1), 4 of which are shown in this figure (b, c). The 
patterns of reactive bands for three lectins, which in the aggregate, 
reacted with salivary components over a broad molecular weight 
range (AAL, JAC and WGA) are shown. LEA was selected due to its 
reactivity with extended lactosamine units, potential sites of terminal 
saccharide modifications related to blood group status
Submandibular/sublingual or parotid saliva
Preparative SDS PAGE
Raster protein bands
In-gel  trypsin digestion
N-glycopeptide capture via lectin
chromatography
PNGase F removal of N-linked glycans
LC- MS/MS and MALDI TOF analyses of 
peptides 
Data analysis to identify N-glycosites, their 
parent glycoproteins, and postulate N-
glycan structures
Fig. 2 Experimental workflow used to identify salivary N-glycosites. 
Parotid and SMSL salivas collected as the ductal secretions were sepa-
rated by preparative SDS-PAGE followed by rastering of the gel bands 
and in-gel trypsin digestion. N-glycopeptides were captured from the 
peptide extracts via their ability to bind to at least one of four lectins 
(AAL, JAC, WGA and/or LEA). After elution and PNGase F removal of 
N-linked glycans, LC–MS/MS was performed to identify the original 
sites of oligosaccharide attachments and the protein scaffolds
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samples from the other donors (compare Figs. 4b and 1a), 
which was also true for the lectin blotting results (AAL, 
jacalin, LEA, and WGA; compare Figs. 4c and 1b). Thus, 
we glycotyped the donors and showed that, in general 
terms, their SMSL and parotid samples had the expected 
repertoire of proteins and glycoproteins.
With regard to an overview of the LC–MS/MS results, 
Additional file 2: Table S1 lists all peptide identifications 
and their associated N-glycosites, including the sites 
identified exclusively in the pilot experiment. The spectra 
are shown in Additional file  3: Figure S2. Overall, 2296 
distinct peptides (54,298 spectral counts) were identi-
fied in the SMSL and parotid salivas of the nonsecretor 
vs. 1928 distinct peptides (43,197 spectral counts) in sali-
vas from the secretor. Using our established criteria (see 
“Methods”), a total of 160 distinct N-glycosites within 
83 glycoproteins were identified. First, we assessed the 
results in terms of the N-glycosites and their parent gly-
coproteins that were common for the donors vs. species 
that were unique based on secretor status. In the com-
mon category, 79 N-glycosites (Fig.  5a, left) and 37 gly-
coproteins (Fig. 5a, right) were detected in both donors. 
More donor-unique N-glycosites were identified in the 
nonsecretor samples (55 from 38 proteins) as compared 
to those of the secretor (26 from 8 proteins).
We then examined, in detail, the distribution of N-gly-
cosites across both donors and saliva types. Out of 160 
distinct N-glycosites, 134 (4249 spectral counts) were 
confirmed in the nonsecretor salivas as compared to 
105 distinct N-glycosites (4562 spectral counts) in the 
secretor samples (Fig.  5b). In 8 cases, 7 involving both 
nonsecretor and secretor samples and 1 instance in the 
analysis of the nonsecretor sample, the two N-glycosites 
resided within a single tryptic peptide. Some N-glycosites 
were observed within peptides of different lengths—due 
to truncation, proteolytic cleavage or missed cleavage 
sites—thus increasing the confidence of their assign-
ments (examples shown in Additional file  2: Table S1, 
Additional file 3: Figure S2).
As shown in Fig.  5b, more N-glycosite species (upper 
panels) were found in the nonsecretor samples (134 
total, upper left) than in those of the secretor (105 total, 
right). This was also true at the level of the glycoproteins 
from which they were derived (75 vs. 45; bottom pan-
els). However, spectral counting suggested that higher 
Fig. 3 Distribution of N-glycosites and glycoproteins between 
parotid and SMSL salivas in the pilot experiment. The results are 
derived from analysis of a single secretor (blood type O, Lea−, Leb−, 
Ley−, and MECA-79 low). SMSL saliva yielded the majority of identifi-
cations. Many fewer were found in parotid saliva or both secretions
Fig. 4 Selection of salivary samples for the N-glycosite profil-
ing experiments. Salivas from 20 donors were screened for blood 
group and selectin ligand (MECA-79) expression. Samples that were 
representative of secretors (S) and nonsecretors (NS) were chosen. 
a Glycoproteins in the “S” sample reacted with antibodies that were 
specific for many blood group determinants: A, B, Lea, Leb, Ley. Secre-
tors tended to have low MECA-79 immunoreactivity as was the case 
with this donor. Glycoprotein expression of blood group determi-
nants in the “NS” sample was limited to Lea (a). Nonsecretors tended 
to have high MECA-79 immunoreactivity as exemplified by this 
donor. b The SDS-PAGE banding patterns of the donor salivas stained 
with Coomassie blue and Alcian silver (left and right, respectively) 
were similar to those of the salivas analyzed in the initial screen (see 
Fig. 1a). c Lectin blotting showed different patterns of reactivity 
among the samples
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copy numbers of N-glycosites were detected in the secre-
tor vs. the nonsecretor sample (Additional file  4: Figure 
S3A). This was despite the fact that the spectral count 
distribution of non-glycosylated peptides was virtually 
identical for both samples types (Additional file 4: Figure 
S3B). Parotid saliva was a major source of N-glycosites 
in the nonsecretor samples (Fig.  5b, upper left) while a 
more balanced contribution of SMSL and parotid salivas 
was observed for the secretor (Fig. 5b, upper right). It is 
interesting to note that this result was consistent with the 
lectin binding patterns of the electrophoretically sepa-
rated samples (Fig. 4c). For both donors, a large fraction 
of detected N-glycosites was common to the two saliva 
types.
In the donor-common category, more than 60  % 
of N-glycosites and their parent glycoproteins were 
observed for both salivas with relatively equal contri-
butions of SMSL and parotid salivas to the remainder 
(Fig.  5c, upper and lower panels). In contrast, parotid 
saliva was the major source of donor-unique N-glycosites 
and glycoproteins in both the nonsecretor and the secre-
tor samples (Fig. 5d, upper and lower panels).
In a cumulative analysis of the entire data set, the rela-
tive abundance of each N-glycosite was estimated by 
the number of spectral counts observed for all degly-
cosylated peptides encompassing that site. The counts 
varied significantly from 1 to more than 400 (433 for 
ZA2G_HUMAN@109 [Zinc-alpha-2-glycoprotein] in 
Fig. 5 Comparison of N-glycosites and glycoproteins by donor and saliva type. Results of analysis of a single secretor and a single nonsecretor are 
shown. a In total, 160 distinct N-glycosites within 83 glycoproteins were identified. Of those, 79 N-glycosites and 37 glycoproteins were common for 
both donors vs. species that were unique based on secretor status. b Overall, many more N-glycosites and glycoproteins were detected in the non-
secretor vs. the secretor sample. The majority of N-glycosites observed in the nonsecretor sample were found in parotid saliva while they were more 
evenly distributed between parotid and SMSL in the secretor sample. Both saliva types shared a large portion of detected N-glycosites. These trends 
were also observed at the glycoprotein level. c In the donor-common category, more than 60 % of N-glycosites and their parent glycoproteins were 
observed for both salivas with relatively equal contributions of SMSL and parotid salivas to the remainder. d In the donor-unique category, parotid 
saliva was the major source of N-glycosites and glycoproteins in both the nonsecretor and the secretor samples
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the nonsecretor and 445 for AMY1_HUMAN@476 
[Amylase] the secretor. The N-glycosites were binned 
into 7 groups based on the number of associated spec-
tral counts (Additional file  5: Figure S4). N-glycosites 
that were common among the donors had similar dis-
tributions in nonsecretor (median/average = 15/49) and 
secretor samples (median/average  =  16/59, left Panel). 
N-glycosites that were unique to a particular donor were 
present in lower abundances (Additional file 5: Figure S4, 
right Panel).
In addition, by virtue of our experimental design, we 
also observed protein isoforms and mutations. For exam-
ple, an N-glycosite unique for isoform 3 of C1q tumor 
necrosis factor-related protein 3 (C1QT3_HUMAN) 
was observed in both donors. Interestingly, we failed to 
detect the canonical structure for the carbonic anhy-
drase 6 (CAH6_Human) tryptic peptide encompassing 
the N-glycosite at position 67. Rather, a common muta-
tion, 68  M→L (dbSNP ID: rs2274328), was found in 
both donor samples (Additional file  3: Figure S2, spec-
trum 26a). In addition, the nonsecretor carried another 
mutation at 90S→G (dbSNP ID: rs2274329) that resided 
with 68  M→L in the same tryptic deglyco-peptide 
(Additional file  3: Figure S2, spectrum 26b), suggest-
ing compound heterozygosity for these variants. To the 
best of our knowledge, this double mutant was not pre-
viously reported. A number of recent studies addressed 
the impact of polymorphic CAH6 structures on salivary 
parameters with the goal of discerning associated pheno-
types of potential clinical significance [22–25].
Together, these data pointed to the potential impact 
of secretor status on utilization of N-glycosites. Namely, 
these simpler glycosylation patterns of the nonsecre-
tor could render the peptide backbone of salivary glyco-
proteins more accessible to glycosyltransferases, which 
would have the net effect of increasing the number of 
unique N-glycosylation sites [26]. However, the secre-
tor sample had more oligosaccharides, in absolute terms, 
which could interact with the lectins we used, e.g., fucose 
residues that bind to AAL. This finding is consistent with 
the ability of secretors to add additional fucose resides to 
the simpler glycan termini typical of nonsecretors. Given 
that one glycosylation site can carry oligosaccharides 
with many different structures, the net effect would likely 
be an increased probability of any given secretor glyco-
peptide binding to AAL.
Lectin performance
Parotid and SMSL salivas from a single secretor and a 
single nonsecretor of the glycotypes described above 
were studied in this series of experiments. Figure  6a 
illustrates the efficiency of the lectins employed in terms 
of the number of N-glycosites identified summed for 
SMSL and parotid salivas. None of the results achieved 
statistical significance in terms of being greater than 2 
SD above or below the mean values. However, trends 
were observed. With regard to the total numbers, AAL 
enrichment tended to lead to the highest number of 
identifications (top panels). There was no difference in 
lectin performance in terms of N-glycosites that were 
common among donors (middle panel). A trend was 
observed in which a higher number of donor-unique 
N-glycosites tended to be captured by AAL from the 
nonsecretor sample (lower panel). Next, we explored 
these results in terms of each saliva type (Fig. 6b). Over-
all, AAL was the only lectin that outperformed the oth-
ers, capturing significantly more N-glycosites from the 
parotid saliva sample of the nonsecretor (upper Panel). 
With regard to N-glycosites that were common among 
donors, the same trend was observed (middle Panel). 
However, we also noted the low recovery of N-glycosites 
from the secretor parotid sample following jacalin cap-
ture. With regard to donor-unique sites, AAL capture 
from the parotid sample of the nonsecretor once again 
led to the highest number of unique identifications 
(lower panel). AAL separation also led to the greatest 
number of unique N-glycosite identifications per sam-
ple-lectin combination (Additional file 6: Figure S5; left 
Panel). However, it was the secretor-SMSL-jacalin com-
bination that resulted in the highest fraction of recov-
ered unique glycopeptides (Additional file  6: Figure S5; 
right Panel).
Finally, we used relative abundance (e.g., spectral 
counts) to compare lectin performance (Fig.  6c). Over-
all, AAL tended to capture the highest number of N-gly-
cosites from the parotid sample of the donor who was 
a secretor; WGA followed by AAL had the highest effi-
ciently in terms of enrichment from parotid saliva of the 
nonsecretor (upper panel). In terms of donor-common 
species (middle panel), the highest number of N-gly-
cosites was observed in the AAL bound fraction of the 
secretor parotid saliva sample. Finally, in terms of donor-
unique sites, WGA captured the highest numbers from 
the nonsecretor parotid saliva sample (lower panel). Of 
note, the latter result was largely driven by the preferen-
tial isolation of FIBB_HUMAN@394.
The overall performance of AAL was in keeping with 
the fact that this lectin binds fucose-containing oligosac-
charides such as the Le determinants that differed among 
our donors. In contrast, N-glycosites that were common 
among donors were more likely to have broader lectin 
affinity perhaps due to their less specialized underlying 
carbohydrate structures. The poor performance of jacalin 
was in accord with its N-acetylgalactosamine specificity, 
a sugar that is typically a component of O-linked oligo-
saccharides, which this study did not interrogate.
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the number of unique identifications is the goal, then 
AAL capture is the best discriminator of N-glycosites as 
applied to parotid saliva samples from nonsecretors vs. 
secretors. If measures of relative abundance are of inter-
est, then WGA ± AAL should be used for enrichment.
Differences in N‑glycosite occupancy between the donors
For this analysis, we compared one secretor and one non-
secretor and considered only common sites with ≥30 
counts per donor. Of the 45 N-glycosites that met these 
criteria, most were highly correlated between the non-
secretor and the secretor samples (r > 0.69 for 60 % and 
0.97 for 26.7  %). Figure  7 (left Panel) shows four exam-
ples according to their lectin binding profiles. To the 
right are four examples of N-glycosites that varied in 
their lectin enrichment levels according to secretor sta-
tus. In addition to differences in individual N-glycosite 
lectin interactions according to secretor status, this anal-
ysis demonstrated interesting differences in glycosyla-
tion between the sites along the same peptide backbone, 
e.g., CF058_HUMAN (N24 vs. N69; r =  0.99 and 0.24, 
respectively).
Other examples included sites that were unique 
among donors (not shown). These included FIBB_
HUMAN@394 (Fibrinogen beta chain), which was 
observed with 304 counts only in parotid saliva of the 
non-secretor. Likewise, FIBG_HUMAN@78 (Fibrino-
gen gamma chain) was unique to parotid saliva of the 
nonsecretor, albeit at a much lower relative abundance 
(18 spectral counts). Both peptides primarily interacted 
with WGA. The other relatively abundant N-glycosites 
that were specific to the nonsecretor samples included 
Fig. 6 Lectin capture efficiency, in terms of number of N-glycosites 
identified and relative abundance. Results shown are of analysis of a 
single secretor and a single nonsecretor. a (upper) Overall, AAL enrich-
ment tended to yield the greatest number of N-glycosites. a (middle) 
With regard to N-glycosites that were common among donors, lectin 
performance did not depend on secretor status (a, lower) whereas 
more N-glycosites tended to be captured by AAL from the nonsecre-
tor sample. b (upper) Overall, AAL demonstrated the greatest capture 
efficiency, enriching more N-glycosites from the parotid saliva sample 
of the nonsecretor (starred). b (middle) With regard to N-glycosites 
that were common among donors, the low level of jacalin capture of 
parotid sites from the secretor sample was evident (starred). b (lower) 
With regard to donor-unique N-glycosites, AAL capture from parotid 
saliva of the nonsecretor was once again most productive in terms of 
a number of identified N-glycosites (starred). c (upper) As to relative 
abundances in terms of spectral counts and overall performance, 
WGA and AAL capture tended to have the highest efficiently. c 
(middle) In terms of donor-common species, the highest number of 
N-glycosites tended to be found in the AAL bound fraction of the 
secretor parotid saliva sample. c (lower) In terms of donor-unique 
sites, WGA captured the highest numbers from the nonsecretor 
parotid saliva sample (starred)
▸
Together these results suggested that the choice of 
lectins for separating saliva samples depends on the 
type of information that is being sought. If maximizing 
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DMBT1_HUMAN@1889 (Deleted in malignant brain 
tumors 1 protein), RNT2_HUMAN@212 (Ribonuclease 
T2) and LG3BP_HUMAN@125 (Galectin-3-binding pro-
tein). Of the 25 secretor-unique N-glycosites, 8 resided in 
FCGBP_HUMAN (IgGFc-binding protein) detected in 
the AAL and/or WGA-retained fractions of SMSL.
Thus, the results of these experiments show that secre-
tor status might play an important role in determin-
ing glycosylation patterns along the peptide backbone. 
The numerous examples of this phenomenon that we 
observed suggested that there could be interesting and 
important biological consequences. Examples include the 
display of carbohydrate receptors that are recognized by 
bacterial adhesins, which could play a role in specifying 
the oral ecology. In this context, it is interesting to note 
that non-secretors are predisposed to chronic periodon-
titis [27] and Sjögren’s syndrome [28]. Perhaps these “hot 
spots” of variable glycosylation could be used as diag-
nostics to predict oral health. Additionally, secretor sta-
tus correlates with susceptibility to or protection from 
numerous systemic conditions, including those with an 
autoimmune etiology such as Crohn’s disease (e.g., [29]). 
Thus, the information that can be gained from analyzing 
salivary expression of blood group antigens could have 
translational potential in terms of the clinical practice of 
medicine and/or dentistry.
Oligosaccharide profiling, nonsecretor vs. secretor salivas
Samples from a single secretor and a single nonsecretor 
were analyzed. Based on donor blood group status, we 
theorized that the glycan profiles of the nonsecretor sam-
ples were characterized by saccharides with fewer fuco-
sylated species. MS-based analyses confirmed this result. 
The parotid profiles are shown in Fig. 8a, b (nonsecretor 
and secretor, respectively); the SMSL profiles are shown 
in Fig.  8c, d (nonsecretor and secretor, respectively). 
Parotid saliva contained high mannose as well as hybrid, 
bi- and tri-antennary structures with higher levels of 
fucosylation in the secretor as compared to the nonse-
cretor sample (marked with black stars). In general, the 
structures we observed (Additional file 7: Table S2) were 
highly correlated with the core fucosylated oligosaccha-
rides that were described by Guile et al. in their analysis 
of the human parotid gland glycome [30]. The same gen-
eral pattern was observed in the SMSL sample with even 
higher levels of fucosylation. Thus, our structural analy-
ses confirmed that, in saliva, the blood group expression 
patterns are borne out at the oligosaccharide structural 
level. We note that other groups have reported differen-
tial glycan complexity of secretors compared to nonse-
cretors [31, 32]. Thomsson et al. detected ABO(H) blood 
group specific structures that decorated O-glycans of sal-
ivary MUC5B obtained from nonsecretors demonstrat-
ing a higher degree of sialylation compared to secretors 
[31]. Similarly, an absence of glycan masses correspond-
ing to H-antigen structures in saliva collected from a 
nonsecretor blood group A individual was observed by 
Everest-Dass et al. [32].
Glycosylation is a post-translational modifica-
tion that affects up to 50  % of secreted and cellular 
Fig. 7 Comparison of the relative lectin capture efficiency for N-glycosites that were detected in the secretor and nonsecretor samples across the 
lectins employed. Spectral counts of glycopeptides encompassing an N-glycosite captured by all four lectins were summed and a percentage con-
tribution of each lectin to this pool was calculated to represent the relative capture efficiency of a specific lectin for a given N-glycosite. (Left panel) 
Examples of four N-glycosites that showed similar lectin binding profiles regardless of secretor status. (Right panel) Examples of four N-glycosites 
that demonstrated disparate lectin binding profiles according to secretor status
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Fig. 8 Glycan profiles of nonsecretors vs. secretors for parotid (a and b) and SMSL (c and d) salivas. N-linked oligosaccharides were released by 
PNGase F digestion and analyzed by MALDI MS. Putative structures of several glycans that were detected are shown. Overall, both salivas contained 
high mannose and hybrid bi- and tri-antennary structures. Higher levels of fucosylation, consistent with the presence of blood group H-antigen 
structure (marked with black stars), were observed in the secretor samples. SMSL glycans had a higher level of fucosylation as compared to those 
observed in parotid saliva. Monoisotopic masses of detected glycans and their structure assignments are listed in Additional file 7: Table S2. Mono-
saccharides are indicated using symbols defined by the Consortium for Functional Glycomics [61]
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proteins [33]. Oligosaccharide addition adds struc-
tural diversity to proteins, and a broad range of glycan 
functions have been reported including roles in innate 
immunity [34, 35] and cancer [36]. There have been 
many studies of the salivary proteome [4, 37], the sali-
vary glycome [32, 38, 39] and glycoproteome [16, 35, 
40–45]. However, the majority have not taken secre-
tor status and blood group antigen expression into 
account. Given the general lack of information about 
the impact of these variables on inter-individual vari-
ations in protein glycosylation, this is a very fruitful 
future direction for further work focused on saliva 
and other body fluids.
Conclusions
We employed a workflow that combined SDS-PAGE pro-
tein fractionation, in-gel tryptic digestion, lectin affin-
ity capture of N-linked glycopeptides and LC–MS/MS 
to interrogate, at a global level, human ductal salivary 
N-glycosylation. We considered two variables—blood 
group (ABO and Lewis) and secretor status. As expected, 
saliva from a nonsecretor (as compared to a secretor) 
carried lower level of fucosylation, as confirmed by mass 
spectrometry analyses of the released N-glycans. Intrigu-
ingly, a significantly higher number of occupied N-gly-
cosites was found in a nonsecretor. Thus, the results of 
this analysis suggested that blood group and secretor sta-
tus are important sources of inter-individual variations 
in salivary glycosylation. The consequences likely include 
significant effects on the oral ecology.
Methods
Unless otherwise noted, all reagents were purchased 
from Thermo-Fisher.
Sample collection
The protocols for collecting human saliva were approved 
by the University of California, San Francisco Committee 
on Human Research and written informed consent was 
obtained from all participants. Briefly, the donors thor-
oughly rinsed their mouths with water prior to sample 
collection, which was done at the same time in all cases 
(early afternoon) to mitigate the possible confounding 
effects of diurnal variation on salivary composition [46]. 
Salivary flow was stimulated by the application of citric 
acid to the tongue. Parotid secretions were obtained by 
using a Lashley cup [12, 47]. SMSL saliva was obtained 
by using a Block and Brotman collector that fit around 
the gland openings [4, 48]. The secretions were col-
lected on ice. Immediately thereafter, a proteinase inhibi-
tor cocktail (Pierce) was added. Then the samples were 
briefly vortexed, divided into 1 mL aliquots and frozen at 
−80 °C.
Analysis of blood group type and secretor status
SMSL and parotid saliva samples from 20 individuals 
were electrophoretically separated (4–12  % polyacryla-
mide gels) and transferred to nitrocellulose. The blots 
were probed with antibodies that recognize the A, B, Ley 
(Abcam), Lea, Leb (Neomarkers) blood group antigens 
and sulfated sialyl Lex (the L-selectin ligand, MECA-79, 
BD Biosciences). The method that we used has been pub-
lished [49].
Lectin screening
We used our published method [50]. Each blot consisted 
of electrophoretically separated samples from 4 indi-
viduals. In all, 16 lectins were screened. They are listed 
in Table I along with the carbohydrate determinants that 
they recognize.
Gel fractionation and digestion
Preparative SDS-PAGE was carried out using a Novex 
4–12  % mini-gel and an X-Cell electrophoresis appa-
ratus (Life Technologies). Either 80 (pilot experiment) 
or 500  µLs of saliva was loaded onto the gel and elec-
trophoresis was performed at 100  V for 2.5  h. Protein 
bands were visualized by staining with SimplyBlue Saf-
eStain Coomassie G-250 (Invitrogen, Life Technologies, 
Carlsbad, CA, USA). The entire gel was rastered into 12 
(pilot experiment) or 18 slices. Each slice was diced into 
1–2  mm pieces, transferred to 2.0-mL Eppendorf tubes 
and in-gel digestion was performed using a modifica-
tion of the method described by Shevchenko et al. [51]. 
Specifically, the first supernatant was removed and gel 
pieces were incubated with 25 mM ammonium bicarbo-
nate (ABC)/50 % acetonitrile (ACN) to extract peptides. 
The second supernatant was removed and combined 
with the first followed by concentration to 25–50 µL in a 
SpeedVac. Then the samples were brought to a volume of 
110 µL with Lectin Buffer A (25 mM Tris, pH 7.4, 50 mM 
sodium chloride, 10  mM calcium chloride, and 10  mM 
magnesium chloride; Sigma Aldrich, St. Louis, MO, USA) 
and passed through 0.2  µm cellulose acetate spin filters 
(Agilent Technologies, Santa Clara, CA, USA) to remove 
the remaining gel fragments.
Lectin column assembly and glycopeptide enrichment
Columns were produced/packed and lectin affinity 
enrichment was performed as previously described [13]. 
Briefly, Artocarpus integrifolia (jacalin, JAC), wheat germ 
agglutinin (WGA), Aleuria aurantia lectin (AAL), or 
Lycopersicon esculentum agglutinin (LEA) lectins (Vec-
tor Labs, Burlingame, CA) were suspended 10–20  mg/
mL in PBS. One hundred mg POROS AL 20  µm beads 
(Applied Biosystems, Foster City, CA, USA) were washed 
twice with 1 mL PBS. Then the lectin solution was added, 
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followed by NaBH3CN to a final concentration of 50 mM 
and the suspension was shaken overnight at room tem-
perature. The beads were washed with 1  mL Tris–HCl 
pH 7.4, then incubated for 30  min in the same buffer 
containing 50  mM NaBH3CN to block any remaining 
aldehyde groups. Five washes with 1  M NaCl were per-
formed. Then the beads were packed into 4.6 × 50-mm 
PEEK HPLC columns by using PBS pumped with a maxi-
mum flow rate that was equal to 2000 psi.
Lectin enrichment was accomplished by using a three-
step isocratic separation method. One hundred µL of 
each trypsin digest was applied to a lectin column. First, 
the column was equilibrated with Lectin Buffer A at a 
flow rate of 50 µL/min. Second, the samples were loaded 
and the column was washed for 9 min. Finally, the bound 
glycopeptides were eluted from the column by using 
0.5 M acetic acid for WGA, LEA, and AAL or 100 mM 
melibiose for jacalin at a flow rate of 500  µL/min for 
5.0 min. Then the column was re-equilibrated with Lec-
tin Buffer A for 6 min at a flow rate of 2.5 mL/min. The 
bound fraction, collected between 9 and 14.2  min, was 
desalted by using Oasis HLB solid phase extraction (SPE) 
cartridges. Briefly, an SPE cartridge was wetted with 3 mL 
of 80  % ACN/0.1  % formic acid (FA) and equilibrated 
with 3  mL of aqueous 0.1  % FA. Then the sample was 
loaded and the column washed with 3 mL 0.1 % FA. Next, 
the peptides were eluted with 1.8 mL 80 % ACN/0.1 % FA 
into 2-mL eppendorf tubes, neutralized with 200 µL 1 M 
ABC and vacuum centrifuged to a volume of ~100 µL.
PNGase F deglycosylation
The eluted N-linked glycopeptides were deglycosylated 
by overnight incubation with 1000 Units of PNGase F 
(Glycerol-Free, New England Biolabs) as described pre-
viously [13]. Then the samples were desalted by using 
MicroSpin Columns, 5–200 µL loading volume (The Nest 
Group, Inc.; Southborough, MA, USA). Samples were 
centrifugally concentrated to dryness and resuspended in 
40 µL 0.1 % FA.
Peptide mass spectrometry
Four microliters from each sample of the original gel 
bands were separated by using a nanoLC ULtra 2D Plus 
system (Eksigent/AB Sciex, Foster City, CA, USA) inter-
faced with a LTQ Orbitrap Velos mass spectrometer 
(ThermoFisher Scientific). The HPLC was interfaced to 
the mass spectrometer using a Captive Spray tapered 
20 µm I.D. tip (Michrom, Auburn, CA) and applied volt-
age of 1.5  kV. The peptides were initially loaded onto a 
guard column (Acclaim PepMap300 C18 300  µm i.d. 
×5  mm, 5  µm particle size, 100  Å pore size; Thermo-
Fisher) and washed with the aqueous loading solvent 
that consisted of 2  % Solvent B (98  % ACN/0.1  % FA) 
in Solvent A (2  % ACN/0.1  % FA), flow rate 10 µL/min 
for 10  min. Then the peptides were separated on a C18 
Acclaim PepMap100 column (75  μm i.d.  ×  150  mm, 
3 µm particle size, 100 Å pore size; ThermoFisher Scien-
tific) heated at 48 °C with a column oven. Peptides were 
eluted at a flow rate of 600 nL/min initially with 2–40 % 
Solvent B for 60 min then 40–90 % B from 60 to 65 min. 
The mass spectrometer was calibrated using a solu-
tion of caffeine, MRFA, and ULtramark 1621 according 
to the manufacturer’s specifications operating in a data 
dependent mode. In positive ion mode, MS scans from 
m/z 300–1500 with a full width at half-maximum reso-
lution of 30,000 were acquired in the Orbitrap analyzer. 
Product ions were generated with a collision cell energy 
of 35 and an activation Q of 0.25. MS/MS scans of the 6 
most abundant ions were acquired in the linear ion trap. 
A mass exclusion time was applied for 30 s with a repeat 
count of 2 and repeat duration of 20 s and an exclusion 
list size of 500.
Database searching and N‑glycosite assignment
Mass spectrometry data files were processed individually 
with integrated peak picking using Mascot (Matrix Sci-
ence, Boston, MA, USA) version 2.2 and Mascot Daemon 
version 2.2.2 to generate MGF files in an extract_msn 
format. Protein identification was accomplished by using 
the MGF files to search the UniProt Swiss-Prot release 
2012_10 with all human isoforms that included 73,982 
protein sequences. ProteinPilot (version 4.5, AB Sciex, 
Foster City, CA, USA) was used to perform the combined 
database searches with all bands from a single lectin and 
secretion. The following ProteinPilot data filters were 
used: carbamidomethylation of cysteines, Orbi/FT MS 
(1–3  ppm), LTQ MS/MS as instrument type, and thor-
ough search. Peptides selected for N-glycosite analyses 
had a minimum confidence of 95  %. N-glycosites were 
assigned as previously described [13], which included uti-
lizing the motif NXS/T where X �= proline and asparagine 
was hydrolyzed to aspartic acid. All MS and MS/MS data 
were manually curated to generate the final N-glycosite 
list. ProteinProspector tools [52] were used to calculate 
theoretical monoisotopic masses and isotopic envelope 
distributions for precursors and m/z values for prod-
uct ions [53]. The results of database searches for both 
donors and secretions were aligned using in house-gen-
erated Java-based software and analyzed in Excel. Esti-
mates of relative abundances employed spectral counts 
[54] using data combined from all gel slices.
Isolation and enrichment of N‑linked glycans
Prior to glycan removal, 100 µL of the SMSL or parotid 
saliva samples was clarified by centrifugation (3000×g) 
at 4 °C for 20 min. according to the procedure described 
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by Everest-Dass et  al. [55]. The supernatant was mixed 
with ice-cold acetone (9:1; v/v) and incubated overnight 
at −20  °C.  The next day, the samples were centrifuged 
to 13,000×g for 10 min. The supernatant was decanted. 
Then the precipitate was dried for 10 min at room tem-
perature before dissolving in 200 µL of 3 M urea. N-gly-
can release was performed as described by Papac et  al. 
with slight modifications [56]. Briefly, a Millipore 96-well 
plate with PVDF membranes (0.45  µm) was washed 
(3× each solvent) with 100  µl of 70  % ethanol, 100  µL 
of water and 100  µL of 3  M guanidine hydrochloride 
(Sigma-Aldrich, Inc.). All washes were performed under 
mild vacuum. Twenty µL of each sample was added per 
well, mixed with 17  mM DTT and incubated at 37  °C 
for 1  h. Then the wells were washed 3× with 250  µl of 
milliQ-water and 50 µL of 25 mM iodoacetamide (Sigma-
Aldrich, Inc.) was added to each well. After 30 min incu-
bation at room temperature, the wells were washed again 
with 250  µL of milliQ-water. Membrane blocking was 
accomplished by room temperature incubation of each 
well with 100  µL of 1  % PVP-360 (Sigma Aldrich, Inc.) 
for 30  min. Finally, the membranes were washed 3× 
with 250 µL milliQ-water. Then each well was filled with 
13  µL milliQ-water, 2  µL of 10× reaction buffer (0.5  M 
sodium phosphate, pH 7.5 at 25 °C) and 5 µL of PNGase 
F enzyme. The plate was incubated overnight at 37  °C; 
empty wells were filled with water to minimize sample 
evaporation.
For enrichment, graphite carbon-packed tips (TopTip™ 
Reversed Phase C-18, Glygen) were prepared accord-
ing to the manufacturer’s protocol. Each tip was washed 
3× with 50 µl of 0.05 % TFA in 60 % ACN, followed by 
3× washes with 50  µL of 0.05  % TFA in water. Glycan 
samples from several wells containing the same saliva 
type were pooled and applied to a single tip, which was 
washed 3× with 50  µL 0.05  % TFA. Captured glycans 
were eluted with 20 µL of 0.05 % TFA in 60 % ACN.
MALDI‑TOF analysis
The matrix (20  mg/mL) was prepared by dissolving 
2′,4′,6′-trihydroxyacetophenone monohydride (THAP; 
Sigma Aldrich, Inc.) in 10 mM ammonium citrate/25 % 
ACN. Samples were mixed with an equal volume of 
THAP matrix and 1  µL was deposited onto a 96-well 
stainless steel MALDI plate (Waters). Orthogonal (o) 
MALDI ion mobility (IM) TOF MS analyses were per-
formed in positive and in negative ion modes on a Synapt 
G2 HD mass spectrometer equipped with a TriWave™ 
IM analyzer (Waters) using “sensitivity” settings with a 
typical resolution of 10,000. Data were analyzed using 
MassLynx software (Waters). The glycan feature cata-
log was generated using DriftScope™ software to extract 
glycan ions and the MaxEnt3 algorithm to deconvolute 
the data and generate monoisotopic m/z values. Gly-
comod software tools [57, 58] were employed to match 
the experimental monoisotopic masses to potential oli-
gosaccharide compositions using the following param-
eters: mass tolerance ±100  ppm; Na+ (positive mode) 
or [M−H]− (negative mode); free/PNGase F released 
N-linked oligosaccharides; and monosaccharide residues 
defined as hexose, N-acetylhexosamine, deoxyhexose and 
sialic acid. Glycoworkbench tools were employed to gen-
erate stick figures of putative glycan structures [59, 60].
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protein reactivity with 16 lectins: [Artocarpus integrifolia (JAC), Wheat germ 
agglutinin (WGA), Aleuria aurantia lectin (AAL), Sambucus nigra (SNA), 
Canavalia ensiformis (Con A), Lens culinaris (LCA), Phaseolus vulgaris eryth-
roagglutinating (PHA-E), Galanthus nivalis (GNA), Lycopersicon esculentum 
agglutinin (Tomato or LEA), Lotus tetragonolobus (LTA), Erythrina christagalli 
(ECA), Datura stramonium (DSA), Glycine max (soybean, SBA), Arachis 
hypogaea (peanut, PNA), Evonymus europaeus (EEA), Vicia villosa (VVA)]. 
AAL, JAC, and WGA interacted with the highest number of glycoproteins 
across a wide molecular weight range. Results are shown for parotid and 
SMSL saliva from 4 donors.
Additional file 2: Table S2. Protein Identifications and Associated 
N-glycosites.
Additional file 3: Figure S2. Annotated MS and MS/MS spectra of 
deglycosylated N-linked glycopeptides identified in parotid and SMSL 
salivas.
Additional file 4: Figure S3. Spectral count distribution for N-glyco- 
and non-glycopeptides in the secretor vs. nonsecretor samples. Spectral 
counting suggested that higher copy numbers of N-glycosites were 
detected in the secretor vs. the nonsecretor sample (Figure S3A). This was 
despite the fact that the spectral count distribution of non-glycosylated 
peptides was virtually identical for both samples types (Figure S3B).
Additional file 5: Figure S4. N-Glycosite distributions binned according 
to spectral counts. (Left Panel) Similar distributions of donor-common 
N-glycosites were observed across all bins regardless of secretor status. 
(Right Panel) Lower abundance N-glycosites were unique to a particular 
donor.
Additional file 6: Figure S5. Efficiency of N-glycopeptide capture by 
lectin, saliva type and secretor status. Sites that were unique to a particular 
sample-lectin combination are shown in red and those that were shared 
among sample-lectin combinations are depicted in blue. (Left Panel) the 
number of N-glycosites and (Right Panel) the relative abundances in terms 
of spectral counts. Green stars denote >2 SD from the mean. In terms of 
unique N-glycosites detected, AAL captured the largest number in parotid 
saliva of the nonsecretor. In terms of relative abundances, JAC captured 
the most copies of unique N-glycosites from SMSL saliva.
Additional file 7: Table S2. PNGase F-Released N-Glycans Detected by 
MALDI Ion Mobility MS.
Page 14 of 16Albertolle et al. Clin Proteom  (2015) 12:29 
hydrophilic-lipophilic-balanced; AAL: Aleuria aurantia Lectin; JAC: Artocarpus 
integrifolia; WGA: wheat germ agglutinin; LEA: Lycopersicon esculentum agglu-
tinin; SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis; 
MUC5B: Mucin 5B; ABC: ammonium bicarbonate; ACN: acetonitrile; SPE: solid 
phase extraction; FA: formic acid; MRFA: L-methionyl-arginyol-phenylalanylala-
nine acetate H2O; MGF: Mascot generic format; TFA: Trifluoroacetic acid; THAP: 
2′,4′,6′-trihydroxyacetophenone monohydride; S: secretor; NS: nonsecretor; 
DTT: dithiothreitol; o: Orthogonal; SNA: Sambucus nigra; Con A: Canavalia 
ensiformis; LCA: Lens culinaris; PHA-E: Phaseolus vulgaris erythroagglutinating; 
GNA: Galanthus nivalis; LTA: Lotus tetragonolobus; ECA: Erythrina christagalli; 
DSA: Datura stramonium; EEA: Evonymus europaeus; VVA: Vicia villosa.
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